Sphingosine-1-phosphate mediates the therapeutic effects of bone marrow mesenchymal stem cell-derived microvesicles...

Area of Science:

• Cell biology
• Biochemistry
• Regenerative medicine

Background:

• Microvesicles (MVs) mediate intercellular communication but their role in cartilage injury is unclear.
• Bone marrow mesenchymal stem cells (MSCs) are a source of MVs with potential therapeutic applications.
• Sphingosine-1-phosphate (S1P) is a bioactive lipid involved in various cellular processes.

Purpose of the Study:

• To investigate the therapeutic potential of MVs in cartilage injury.
• To elucidate the mechanisms underlying MV-mediated effects on chondrocytes.
• To identify key molecules involved in MV uptake and function.

Main Methods:

• Quantification of S1P in MVs derived from MSCs.
• In vitro co-culture of human chondrocytes with MVs.
• Assessment of chondrocyte proliferation, apoptosis, and MV uptake.
• In vivo studies to evaluate therapeutic effects of MVs.
• Use of antibodies to block CD44 and S1P signaling.

Main Results:

• MVs exhibited higher S1P levels than parent MSCs, mediated by Sphingosine Kinase 1 (SphK1).
• MVs increased chondrocyte proliferation and inhibited apoptosis via S1P receptor 1 (S1PR1) activation.
• CD44 on MVs mediated their uptake by chondrocytes.
• Blocking S1P neutralized the therapeutic effects of MVs in vivo.

Conclusions:

• MVs demonstrate significant therapeutic potential for cartilage injury treatment.
• CD44-mediated uptake and the S1P/S1PR1 axis are crucial for MV therapeutic efficacy.
• These findings highlight MVs as promising cell-free therapeutic agents for cartilage regeneration.